The rounds this investor is named on, who it invests beside, and where it shows up.
Named on one round in the feed.
Identifying, incubating and growing future industry leaders in life sciences.
Venture capitalShanghai, P.R. Chinaquancapital.comSince 2025-01-10
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Windward Bio Windward Bio develops ultra-long-acting monoclonal antibodies for the treatment of serious respiratory and dermatologic diseases, targeting conditions like asthma and COPD. | Series A Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $200M | 2025-01-10 | [ PART ] |